Feds Hike Cyber Oversight, Telehealth Growth Increases Risks

Prior to Monday’s White House cybersecurity alert, federal regulators put the health care industry on notice they were stepping up oversight of private sector cybersecurity measures and stakeholders noted the rise in telehealth had increased cyber risks. The warnings from public and private speakers at the recent HIPAA Summit sponsored by Global Health Care presaged the president’s warning Monday ( March 21) of potential Russia cyberattacks on critical U.S. infrastructure . Ilana Peters, former acting deputy director of health information...
Article Type: 
Inside Telehealth Daily News
Site Name: 
InsideHealthPolicy.com
Author: 
Jessica Karins
Topics: 
Not Top Story

Stakeholders Seek Telehealth Flexibilities In Broader Plan To Expand Home Dialysis

Innovate Kidney Care’s broader agenda to expand home dialysis includes a smattering of new telehealth flexibilities among the provisions it recommends CMS and Congress adopt to make treatments more widely accessible to patients. The group says expanded use of telehealth would aid doctors and patients in remote monitoring and allow virtual training of patients who are participating in home dialysis. Prior to the public health emergency, home dialysis patients were required to have a face-to-face clinical examination of the vascular...
Article Type: 
Inside Telehealth Daily News
Site Name: 
InsideHealthPolicy.com
Author: 
Cara Smith
Topics: 
Not Top Story

White House Warns Industry: Russia Is ‘Exploring Options’ For Cyber Attacks, Boost Defenses

The White House on Monday (March 21) warned that Russia is “exploring options” for launching cyber attacks against U.S. critical infrastructure and that industry needs to take steps to heighten security. In a White House press briefing, Deputy National Security Advisor for Cyber Anne Neuberger sent the following message to companies: “Lock your digital doors, make it harder for actors, make them do more work.” The White House alert comes after HHS officials recently warned health care stakeholders to hike...
Article Type: 
Inside Telehealth Daily News
Site Name: 
InsideHealthPolicy.com
Author: 
Jessica Karins
Secondary Author(s): 
Charlie Mitchell
Topics: 
Not Top Story

Stakeholders Watch For Jackson’s Health Care Thoughts During SCOTUS Nomination Hearings, HHS To Cut Off Uninsured COVID-19 Claims Unless Relief Passed

Health care stakeholders started looking for hints on how Judge Ketanji Brown Jackson might tackle health care cases as the Senate Judiciary Committee on Monday (March 21) kicked off its high-profile hearing on her nomination to the Supreme Court, while the Senate health committee will continue its look at mental health and stakeholders take stock of HHS Secretary Xavier Becerra’s Friday outline of his upcoming plans for the department. Meanwhile, the administration warns HHS will likely stop accepting claims this...
Overline: 
Health Insider
Article Type: 
Health Insider
Site Name: 
InsideHealthPolicy.com
Author: 
Michelle M. Stein
Secondary Author(s): 
Bridget Early

Loud Opposition To March-In Petition Might Signal Close Call

About 80 drug industry groups and individuals are urging the National Institutes of Health to reject a petition for the government to march in on Xtandi patents to make a cheaper generic to the prostate cancer drug with an annual list price of about $190,000. The March 17 letter is a sign that the industry is worried the Biden administration is considering the march-in petition more seriously than past administrations have considered similar petitions. Four prostate cancer patients petitioned the...
Article Type: 
Inside Drug Pricing Daily News
Site Name: 
InsideHealthPolicy.com
IDP Issue: 
Inside Drug Pricing - 03/28/2022
IDP Volume: 
Vol. 5, No. 13
Author: 
Gabrielle Wanneh

Chamber Raises Early Objections To California Vaccine-Mandate Bill

The California Chamber of Commerce (CalChamber) is raising several concerns with a newly proposed state bill that would mandate COVID-19 vaccination as a condition of employment for all public and private sector workers, including that employers will find it harder to hire and retain workers, and could face burdensome litigation over their compliance. “[W]e had a lot of members concerned about retention and recruitment,” said Ashley Hoffman, a CalChamber labor policy advocate, during a March 11 podcast about the vaccination...
Article Type: 
Daily News
Tags: 
corona
Site Name: 
InsideHealthPolicy.com
FDA Issue: 
FDA Week - 03/25/2022
FDA Volume: 
Vol. 28, No. 12
CMS Issue: 
Inside CMS - 03/24/2022
CMS Volume: 
Vol. 25, No. 12
Author: 
INSIDE OSHA
Topics: 
ISSUE: INSIDE CMS
ISSUE: FDA WEEK
Mid Day E-mail
Coronavirus
Rx Drugs

White House Warns Industry: Russia Is ‘Exploring Options’ For Cyber Attacks, Boost Defenses

The White House on Monday (March 21) warned that Russia is “exploring options” for launching cyber attacks against U.S. critical infrastructure and that industry needs to take steps to heighten security. In a White House press briefing, Deputy National Security Advisor for Cyber Anne Neuberger sent the following message to companies: “Lock your digital doors, make it harder for actors, make them do more work.” The White House alert comes after HHS officials recently warned health care stakeholders to hike...
Article Type: 
Daily News
Tags: 
telehealth
cyber
Site Name: 
InsideHealthPolicy.com
FDA Issue: 
FDA Week - 03/25/2022
FDA Volume: 
Vol. 28, No. 12
CMS Issue: 
Inside CMS - 03/24/2022
CMS Volume: 
Vol. 25, No. 12
Author: 
Jessica Karins
Secondary Author(s): 
Charlie Mitchell
Topics: 
ISSUE: INSIDE CMS
ISSUE: FDA WEEK
Mid Day E-mail
Cybersecurity

FDA Panel Will Discuss Regulatory Plan For Future COVID-19 Boosters

FDA’s vaccine advisers will meet April 6 to discuss the regulatory framework for future COVID-19 booster shots, including the process for selecting different strains for coronavirus vaccines to address current and emerging variants, the agency announced Monday (March 21). The advisory committee will not discuss or vote on any specific product applications, the agency said. The agency, its vaccine advisory committee, and representatives from the Centers for Disease Control and Prevention and the National Institutes of Health will discuss what...
Article Type: 
Daily News
Tags: 
vaccine
corona
drug-trial
drug-safety
ACs
NIH
Site Name: 
InsideHealthPolicy.com
FDA Issue: 
FDA Week - 03/25/2022
FDA Volume: 
Vol. 28, No. 12
Author: 
Beth Wang
Topics: 
ISSUE: FDA WEEK
Mid Day E-mail
Coronavirus
Rx Drugs

W&M GOP Holds Mock Aduhelm Hearing Tue.; Dem Inaction On Other Fronts Provides Insights

Editor's Note: The original version of the Regimen incorrectly said E&C would hold the mock Aduhelm hearing. The updated version below notes the hearing is being held by W&M, and links to IDP's earlier story. House Ways & Means Republicans on Tuesday (March 22) hold a mock hearing to protest CMS’ proposed restrictive national coverage policy for the Alzheimer’s drug Aduhelm, which demonstrates the likely change in tone toward drug prices that will take place if Republicans...
Article Type: 
Inside Drug Pricing Regimen
Site Name: 
InsideHealthPolicy.com
IDP Issue: 
Inside Drug Pricing - 03/21/2022
IDP Volume: 
Vol. 5, No. 12
Author: 
John Wilkerson

Pages

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.